Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Amortization (2018 - 2019)

Historic Amortization for Cue Biopharma (CUE) over the last 2 years, with Q4 2019 value amounting to $3.9 million.

  • Cue Biopharma's Amortization fell 661.68% to $3.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $3.9 million, marking a year-over-year decrease of 661.68%. This contributed to the annual value of $3.9 million for FY2019, which is 661.68% down from last year.
  • Cue Biopharma's Amortization amounted to $3.9 million in Q4 2019, which was down 661.68% from $4.1 million recorded in Q4 2018.
  • Cue Biopharma's Amortization's 5-year high stood at $4.1 million during Q4 2018, with a 5-year trough of $3.9 million in Q4 2019.